News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Dominick Latrémouille-Viau

Articles by Dominick Latrémouille-Viau

24 Patient Preferences for CDK4/6 Inhibitor Treatments in HR+/HER2– Early Breast Cancer: A Discrete Choice Survey Study

24 Patient Preferences for CDK4/6 Inhibitor Treatments in HR+/HER2– Early Breast Cancer: A Discrete Choice Survey Study

ByErica L. Mayer, MD, MPH,Mary Lou Smith,Annie Guérin,Dominick Latrémouille-Viau,Nisha C. Hazra,Yan Meng,Wendi Qu,Remi Bellefleur,Vaidyanathan Ganapathy,Liz Santarsiero,Robert Morlock,Maryam Lustberg

August 2nd 2024

Latest Updated Articles

Trending on CancerNetwork

Atezolizumab Combo Elicits No Significant Benefit in Ovarian Cancer

Glofitamab/Polatuzumab Vedotin Exhibits Response Durability in R/R LBCL

How Will Gastrointestinal Cancer Standards of Care Change? An ESMO Recap

Muscle RNome Analysis Reveals 2 Molecular Subtypes Associated With Cancer Cachexia

Forming CUTNETs: A Joint Venture Between Surgery and Oncology in NETs

© 2025 MJH Life Sciences^®

All rights reserved.